Serbian Conference 2025
As part of the European ME Alliance, and supporter of the European ME Research Group (EMERG) Invest in ME Research was recently invited to present at the The 3rd International Symposium on Chronic Fatigue Syndrome, Long COVID and Post-Infection Syndromes — Serbia, on 14 November 2025 at the Institute for Cardiovascular Diseases “Dedinje” in Belgrade, Serbia.
The symposium included representatives of the European ME Alliance (EMEA), the European ME Research Group (EMERG), and the Young EMERG early career researcher group.
IiMER Presentation
Organised by Professor Branislav Milovanović, President of the Section for the Autonomic Nervous System of the Serbian Medical Society and member of EMERG, the meeting took place under the patronage of the Ministry of Health of Serbia with the support of professional and patient organisations across the region.
Presenters included:
- Milovan Bojić, Director of Institute for Cardiovascular Diseases-Dedinje
- Zlatibor Lončar, Minister of Health of the Republic of Serbia
- Bela Balint, Minister of Science of the Republic of Serbia
- Milan Nedeljkovic, President of Serbian Medical Society
- Ivana Nedeljković, President of Cardiology Society of Serbia
| Invest in ME Research
The European ME Alliance will have more detail on their web site but the attached video was that which Invest in ME Research presented - with a theme on collaboration and moving to the most rapid method of achieving progress, without reinventing everything again, as seems to be repeated in UK every few years.
A key charity objective is developing and supporting European research through both the European ME Research Group (EMERG) and Young EMERG. This continued strategy is vital—especially as we strive to attract researchers from other fields and build long-term investment in ME science. Together with our partners in the European ME Alliance (EMEA) and the European ME Clinicians in EMERG, this provides an existing European research model. Our goal remains clear: to fund and facilitate the kind of research that offers the best chance of advancing understanding and treatment for ME - rapidly.
Further Information
Last Update November 2025